Aberdeen Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.4M Buy
522,963
+58,578
+13% +$1.5M 0.02% 513
2026
Q1
$10.9M Sell
464,385
-279,540
-38% -$5.06M 0.02% 580
2025
Q4
$10.6M Buy
743,925
+312,172
+72% +$5.91M 0.02% 602
2025
Q3
$10.7M Buy
431,753
+83,636
+24% +$1.87M 0.02% 592
2025
Q2
$7.9M Buy
348,117
+239,595
+221% +$5.68M 0.01% 650
2025
Q1
$3.29M Sell
108,522
-48,771
-31% -$1.86M 0.01% 718
2024
Q4
$6.24M Buy
157,293
+59,824
+61% +$2.7M 0.01% 609
2024
Q3
$6.18M Sell
97,469
-5,824
-6% -$420K 0.01% 618
2024
Q2
$6.98M Hold
103,293
0.01% 572
2024
Q1
$8.18M Buy
103,293
+2,381
+2% +$195K 0.02% 584
2023
Q4
$7.85M Buy
+100,912
New +$7.47M 0.02% 596

Other funds holding ACHC

Aberdeen Group's ACHC Position: Q2 2026 in Review

Aberdeen Group increased its Acadia Healthcare (ACHC) stake by 13% in Q2 2026, buying an estimated $1.5M and bringing the position to 522,963 shares worth $15.4M. The position accounts for 0.02% of the portfolio, ranked #513.

Aberdeen Group first reported a position in ACHC in Q4 2023 and has held it in 11 quarters since. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Aberdeen Group held 522,963 shares of Acadia Healthcare worth $15.4M as of Q2 2026.
  • Aberdeen Group bought 58,578 Acadia Healthcare shares in Q2 2026, an estimated $1.5M.
  • Acadia Healthcare made up 0.02% of Aberdeen Group's portfolio in Q2 2026, its #513 holding.
  • Aberdeen Group first reported a position in Acadia Healthcare in Q4 2023 and has held it in 11 quarters since.
  • 314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.